TRIM26 and hepatocellular carcinoma: This study uncovered that the E3 ubiquitin ligase activity of TRIM26 was previously shown to target ZEB1, an oncoprotein crucial for the development of HCC and thus to act as a tumor suppressor in HCC (8).